{"basic_info": {"ticker": "300267", "exchange": "XSHE", "bloomberg_ticker": "300267 CH Equity", "name": "HUNAN ER-KANG PHARMACEUTI -A", "industry": "Pharmaceuticals", "name_chinese_simplified": "尔康制药", "period": "2020", "market_value": 8601062400, "total_income": 1202263533, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 648794181, "business_income_over_total_income": 0.5396438993546351}, {"shariah_compliance": "unknown", "income": 553469351, "business_income_over_total_income": 0.46035609981360054}], "details": [{"business_activity_cn": "淀粉及淀粉囊系列产品", "business_activity_en": "Starch and starch capsule products", "income": 578521310, "business_income_over_total_income": 0.4811934273315433, "shariah_compliance": "compliant"}, {"business_activity_cn": "磺胺嘧啶", "business_activity_en": "Sulfadiazine", "income": 70272871, "business_income_over_total_income": 0.058450472023091796, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 4523650, "business_income_over_total_income": 0.0037626110048536257, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 548945701, "business_income_over_total_income": 0.4565934888087469, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.08158329989549908, "shariah_compliance": "compliant", "amount_over_market_value": 0.08158329989549908}]}